We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
-1.93%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$6.9B
AUM Growth
-$640M
Cap. Flow
-$445M
Cap. Flow %
-6.44%
Top 10 Hldgs %
46.9%
Holding
379
New
105
Increased
68
Reduced
108
Closed
98

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$249M
2
ELV icon
Elevance Health
ELV
+$208M
3
FISV
Fiserv Inc
FISV
+$169M
4
SSNC icon
SS&C Technologies
SSNC
+$142M
5
USFD icon
US Foods
USFD
+$122M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.55%
2 Technology 22.52%
3 Healthcare 17.59%
4 Communication Services 10.97%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$61.9B
$64.3M 0.93%
765,739
-811,860
-51% -$68.3M
KKR icon
27
KKR & Co
KKR
$89.2B
$48.7M 0.71%
1,925,572
-2,455,018
-56% -$58.8M
ADBE icon
28
Adobe
ADBE
$89.5B
$48.7M 0.71%
165,139
-238,950
-59% -$66.4M
GPK icon
29
Graphic Packaging
GPK
$3.26B
$45.9M 0.67%
3,285,568
-4,863,964
-60% -$65.2M
ATRA icon
30
Atara Biotherapeutics
ATRA
$71.2M
$44.9M 0.65%
89,299
+54,468
+156% +$38.4M
EXP icon
31
Eagle Materials
EXP
$6.6B
$38M 0.55%
410,262
-1,379,493
-77% -$122M
BUD icon
32
AB InBev
BUD
$158B
$37.9M 0.55%
427,645
-553,347
-56% -$47.5M
SNPS icon
33
Synopsys
SNPS
$71.5B
$35.6M 0.52%
276,299
-182,490
-40% -$22M
WYNN icon
34
Wynn Resorts
WYNN
$10.1B
$34.2M 0.5%
275,777
-617,247
-69% -$79.4M
TAK icon
35
Takeda Pharmaceutical
TAK
$55.1B
$29.8M 0.43%
1,682,888
-58,778
-3% -$1.07M
SBUX icon
36
Starbucks
SBUX
$118B
$25.7M 0.37%
+306,990
New +$24.1M
AMZN icon
37
Amazon
AMZN
$2.5T
$25.4M 0.37%
267,880
+77,680
+41% +$7.24M
NFLX icon
38
Netflix
NFLX
$292B
$24.1M 0.35%
+656,800
New +$23.7M
DECK icon
39
Deckers Outdoor
DECK
$13.3B
$24.1M 0.35%
822,120
-383,940
-32% -$9.98M
CASY icon
40
Casey's General Stores
CASY
$31.9B
$22.9M 0.33%
+146,590
New +$20M
LULU icon
41
lululemon athletica
LULU
$13B
$22.4M 0.32%
124,390
+42,480
+52% +$7.38M
DAL icon
42
Delta Air Lines
DAL
$55.9B
$17.5M 0.25%
307,690
+120,390
+64% +$6.75M
SKX
43
DELISTED
Skechers
SKX
$16.7M 0.24%
+531,070
New +$16.4M
JACK icon
44
Jack in the Box
JACK
$278M
$16.6M 0.24%
204,390
+76,540
+60% +$6.18M
VFC icon
45
VF Corp
VFC
$6.68B
$16.6M 0.24%
+190,300
New +$16.4M
M icon
46
Macy's
M
$6.15B
$16.2M 0.23%
752,610
+375,620
+100% +$8.54M
WING icon
47
Wingstop
WING
$3.68B
$15.9M 0.23%
167,890
+36,240
+28% +$2.95M
DRI icon
48
Darden Restaurants
DRI
$22.5B
$15.7M 0.23%
129,120
+76,100
+144% +$9.06M
LITE icon
49
Lumentum
LITE
$59.4B
$15M 0.22%
+281,158
New +$15M
TXRH icon
50
Texas Roadhouse
TXRH
$12.7B
$14.4M 0.21%
+268,496
New +$15.1M

Similar funds

Maverick Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Maverick Capital held 379 positions worth $6.9B, down 8.5% from $7.54B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Maverick Capital withdrew a net $445M in Q2 2019, closing 98 positions and reducing 108 holdings. Its most notable exit was Elevance Health, an estimated $208M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Maverick Capital opened a new position in MGM Resorts International worth $129M.

  • Maverick Capital's largest Q2 2019 buy was MGM Resorts International: 4,527,373 shares worth $129M.
  • Maverick Capital added most to Humana in Q2 2019, an estimated $237M increase.
  • Maverick Capital's biggest Q2 2019 reduction was Microsoft, cutting an estimated $249M.
  • Maverick Capital fully exited Elevance Health in Q2 2019, selling an estimated $208M.
  • Maverick Capital's ten largest holdings make up 47% of its $6.9B portfolio in Q2 2019.
  • Maverick Capital opened 105 new positions and closed 98 in Q2 2019.
  • Maverick Capital's portfolio value fell 8.5% quarter-over-quarter to $6.9B.

Based on Maverick Capital's 13F filing for Q2 2019, filed 14 Aug 2019.